Crossmark

Stachydrine Protects Against Diabetic Nephropathy Through Modulating Autophagy, Oxidative Stress, and Apoptosis via the AMPK/mTOR and Nrf2/HO-1 Pathways

Crossref DOI link: https://doi.org/10.1007/s43450-025-00669-1

Published Online: 2025-09-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xie, Fang

Wang, Chao
Funding

Funding for this research was provided by:

Clinical Medical Research Translation Special Project of Anhui Provincial Science and Technology Department (202204295107020034)
License Information

Text and Data Mining valid from 2025-09-04

Version of Record valid from 2025-09-04
More Information

Article History

Received: 4 March 2025

Accepted: 10 June 2025

First Online: 4 September 2025

Declarations

:

: Experimental procedures and animal treatment were confirmed to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health and were approved by the Animal Ethics Committee of Bengbu Medical University (Ethical Animal Science No. 420 [2023]; May 26, 2023).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below